Download PDF
Semin Respir Crit Care Med 2019; 40(03): 402-409
DOI: 10.1055/s-0039-1695050
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pleural Disease in Women

Angela Christine Argento
1   Interventional Pulmonary, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
,
Colin T. Gillespie
1   Interventional Pulmonary, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
› Author Affiliations
Further Information

Publication History

Publication Date:
16 September 2019 (online)

    Permissions and Reprints

Abstract

There are several pleural diseases that occur either predominantly or exclusively in females. Most of these entities are related to obstetric or gynecological conditions. In this article, we will provide an overview of Meigs' syndrome, ovarian hyperstimulation syndrome, endometriosis, catamenial pneumothorax, catamenial hemothorax, pleural effusions that occur in the peripartum period, lymphangioleiomyomatosis, and malignant pleural effusions related to breast cancer. As most of these diagnoses are rare, considerable expertise is required to identify, diagnose, and manage these patients. The aim of this article is to present an overview of the most common forms of pleural disease affecting women, and to provide an easy reference source on current best practice.

Keywords

pleural disease - women - pleural effusion - pneumothorax - hemothorax - catamenial - Meigs' syndrome - breast cancer - ovarian hyperstimulation syndrome
 

  • References

  • 1 Meigs JV, Dresser R. Carcinoma of the cervix treated by the Roentgen ray and radium. Ann Surg 1937; 106 (04) 653-667
    CrossrefPubMedGoogle Scholar
  • 2 Lurie S. Meigs' syndrome: the history of the eponym. Eur J Obstet Gynecol Reprod Biol 2000; 92 (02) 199-204
    CrossrefPubMedGoogle Scholar
  • 3 Riker D, Goba D. Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome. J Bronchology Interv Pulmonol 2013; 20 (01) 48-51
    CrossrefPubMedGoogle Scholar
  • 4 Agranoff D, May D, Jameson C, Knowles GK. Pleural effusion and a pelvic mass. Postgrad Med J 1998; 74 (871) 265-267
    CrossrefPubMedGoogle Scholar
  • 5 Meigs JV. Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol 1954; 3 (05) 471-486
    PubMedGoogle Scholar
  • 6 Shiau CS, Chang MY, Hsieh CC, Hsieh TT, Chiang CH. Meigs' syndrome in a young woman with a normal serum CA-125 level. Chang Gung Med J 2005; 28 (08) 587-591
    PubMedGoogle Scholar
  • 7 Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol 2001; 184 (03) 354-355
    CrossrefPubMedGoogle Scholar
  • 8 Ishiko O, Yoshida H, Sumi T, Hirai K, Ogita S. Vascular endothelial growth factor levels in pleural and peritoneal fluid in Meigs' syndrome. Eur J Obstet Gynecol Reprod Biol 2001; 98 (01) 129-130
    CrossrefPubMedGoogle Scholar
  • 9 Kirschner PA. Porous diaphragm syndromes. Chest Surg Clin N Am 1998; 8 (02) 449-472
    PubMedGoogle Scholar
  • 10 Meigs J, Armstrong SH, Hamilton HH. A further contribution to the syndrome of fibroma of the ovary with fluid in the abdomen and chest, Meigs' syndrome. Am J Obstet Gynecol 1943; 46: 19-37
    CrossrefPubMedGoogle Scholar
  • 11 Jimerson SD. Pseudo-Meigs's syndrome. An unusual case with analysis of the effusions. Obstet Gynecol 1973; 42 (04) 535-537
    CrossrefPubMedGoogle Scholar
  • 12 Krenke R, Maskey-Warzechowska M, Korczynski P. , et al. Pleural effusion in Meigs' syndrome-transudate or exudate?: systematic review of the literature. Medicine (Baltimore) 2015; 94 (49) e2114
    PubMedGoogle Scholar
  • 13 Hurlow RA, Greening WP, Krantz E. Ascites and hydrothorax in association with struma ovarii. Br J Surg 1976; 63 (02) 110-112
    CrossrefPubMedGoogle Scholar
  • 14 Neustadt JE, Levy RC. Hemorrhagic pleural effusion in Meig's syndrome. JAMA 1968; 204 (01) 81-82
    CrossrefPubMedGoogle Scholar
  • 15 Patsner B. Meigs syndrome and “false positive” preoperative serum CA-125 levels: analysis of ten cases. Eur J Gynaecol Oncol 2000; 21 (04) 362-363
    PubMedGoogle Scholar
  • 16 Lin JY, Angel C, Sickel JZ. Meigs syndrome with elevated serum CA 125. Obstet Gynecol 1992; 80 (3, Pt 2): 563-566
    PubMedGoogle Scholar
  • 17 Nemeth AJ, Patel SK. Meigs syndrome revisited. J Thorac Imaging 2003; 18 (02) 100-103
    CrossrefPubMedGoogle Scholar
  • 18 Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update 2003; 9 (01) 77-96
    CrossrefPubMedGoogle Scholar
  • 19 Di Carlo C, Savoia F, Ferrara C, Tommaselli GA, Bifulco G, Nappi C. Case report: a most peculiar family with spontaneous, recurrent ovarian hyperstimulation syndrome. Gynecol Endocrinol 2012; 28 (08) 649-651
    CrossrefPubMedGoogle Scholar
  • 20 Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment. J Assist Reprod Genet 2014; 31 (02) 205-211
    CrossrefPubMedGoogle Scholar
  • 21 Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet 2010; 27 (2–3): 121-128
    CrossrefPubMedGoogle Scholar
  • 22 Nastri CO, Teixeira DM, Moroni RM, Leitão VM, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound Obstet Gynecol 2015; 45 (04) 377-393
    CrossrefPubMedGoogle Scholar
  • 23 Light RW, Lee G. Textbook of Pleural Diseases. 2nd ed. London, FL: Hodder Arnold Publication; 2008
    Google Scholar
  • 24 Chen CD, Wu MY, Chen HF, Chen SU, Ho HN, Yang YS. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1999; 72 (02) 286-292
    CrossrefPubMedGoogle Scholar
  • 25 Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Asch RH. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril 1995; 63 (02) 268-272
    CrossrefPubMedGoogle Scholar
  • 26 Wang TH, Horng SG, Chang CL. , et al. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 2002; 87 (07) 3300-3308
    CrossrefPubMedGoogle Scholar
  • 27 Ajonuma LC. Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?. Med Hypotheses 2008; 70 (06) 1174-1178
    CrossrefPubMedGoogle Scholar
  • 28 Ajonuma LC, Ajuonuma MU, Ajuonuma BC, Ogbedeagu VM, Ajuonuma JU, Chukwu CL. EG-VEGF concentrations may predict OHSS. Fertil Steril 2011; 95 (07) e37 , author reply e38
    CrossrefPubMedGoogle Scholar
  • 29 Evbuomwan IO, Davison JM, Murdoch AP. Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox. Fertil Steril 2000; 74 (01) 67-72
    CrossrefPubMedGoogle Scholar
  • 30 Light RW. Pleural Diseases, 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2007
    Google Scholar
  • 31 Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod 1997; 12 (06) 1129-1137
    CrossrefPubMedGoogle Scholar
  • 32 Carizza C, Abdelmassih V, Abdelmassih S. , et al. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. Reprod Biomed Online 2008; 17 (06) 751-755
    CrossrefPubMedGoogle Scholar
  • 33 Fábregues F, Peñarrubia J, Vidal E, Casals G, Vanrell JA, Balasch J. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study. Fertil Steril 2004; 82 (04) 827-833
    CrossrefPubMedGoogle Scholar
  • 34 Lee KH, Kim SH, Jee BC. , et al. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome. Fertil Steril 2010; 93 (07) 2274-2280
    CrossrefPubMedGoogle Scholar
  • 35 Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning Jr RV. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994; 9 (05) 792-799
    CrossrefPubMedGoogle Scholar
  • 36 Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73 (05) 901-907
    CrossrefPubMedGoogle Scholar
  • 37 Papanikolaou EG, Pozzobon C, Kolibianakis EM. , et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 2006; 85 (01) 112-120
    CrossrefPubMedGoogle Scholar
  • 38 Papanikolaou EG, Tournaye H, Verpoest W. , et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 2005; 20 (03) 636-641
    CrossrefPubMedGoogle Scholar
  • 39 Qasim SM, Karacan M, Kemmann E. An eight year review of hospitalization for ovarian hyperstimulation syndrome. Clin Exp Obstet Gynecol 1997; 24 (02) 49-52
    PubMedGoogle Scholar
  • 40 Gregory WT, Patton PE. Isolated pleural effusion in severe ovarian hyperstimulation: a case report. Am J Obstet Gynecol 1999; 180 (6, Pt 1): 1468-1471
    CrossrefPubMedGoogle Scholar
  • 41 Rabinerson D, Shalev J, Royburt M, Ben-Rafael Z, Dekel A. Severe unilateral hydrothorax as the only manifestation of the ovarian hyperstimulation syndrome. Gynecol Obstet Invest 2000; 49 (02) 140-142
    CrossrefPubMedGoogle Scholar
  • 42 Lobo DN, Stanga Z, Aloysius MM. , et al. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38 (02) 464-470
    CrossrefPubMedGoogle Scholar
  • 43 McClelland DB. ABC of transfusion. Human albumin solutions. BMJ 1990; 300 (6716): 35-37
    CrossrefPubMedGoogle Scholar
  • 44 Youssef MA, Al-Inany HG, Evers JL, Aboulghar M. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2011; (02) CD001302
    PubMedGoogle Scholar
  • 45 Abramov Y, Elchalal U, Schenker JG. Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 1999; 71 (04) 645-651
    CrossrefPubMedGoogle Scholar
  • 46 Augoulea A, Lambrinoudaki I, Christodoulakos G. Thoracic endometriosis syndrome. Respiration 2008; 75 (01) 113-119
    CrossrefPubMedGoogle Scholar
  • 47 Hasdemir PS, Ikiz N, Ozcakir HT, Kara E, Guvenal T. Endometriosis associated with relapsing ascites and pleural effusions. J Obstet Gynaecol 2015; 35 (04) 419
    CrossrefPubMedGoogle Scholar
  • 48 Muneyyirci-Delale O, Neil G, Serur E, Gordon D, Maiman M, Sedlis A. Endometriosis with massive ascites. Gynecol Oncol 1998; 69 (01) 42-46
    CrossrefPubMedGoogle Scholar
  • 49 Bhojawala J, Heller DS, Cracchiolo B, Sama J. Endometriosis presenting as bloody pleural effusion and ascites-report of a case and review of the literature. Arch Gynecol Obstet 2000; 264 (01) 39-41
    CrossrefPubMedGoogle Scholar
  • 50 Shepard MK, Mancini MC, Campbell Jr GD, George R. Right-sided hemothorax and recurrent abdominal pain in a 34-year-old woman. Chest 1993; 103 (04) 1239-1240
    CrossrefPubMedGoogle Scholar
  • 51 Lillington GA, Mitchell SP, Wood GA. Catamenial pneumothorax. JAMA 1972; 219 (10) 1328-1332
    CrossrefPubMedGoogle Scholar
  • 52 Maurer ER, Schaal JA, Mendez Jr FL. Chronic recurring spontaneous pneumothorax due to endometriosis of the diaphragm. J Am Med Assoc 1958; 168 (15) 2013-2014
    CrossrefPubMedGoogle Scholar
  • 53 Alifano M. Catamenial pneumothorax. Curr Opin Pulm Med 2010; 16 (04) 381-386
    CrossrefPubMedGoogle Scholar
  • 54 Alifano M, Jablonski C, Kadiri H. , et al. Catamenial and noncatamenial, endometriosis-related or nonendometriosis-related pneumothorax referred for surgery. Am J Respir Crit Care Med 2007; 176 (10) 1048-1053
    CrossrefPubMedGoogle Scholar
  • 55 Alifano M, Roth T, Broët SC, Schussler O, Magdeleinat P, Regnard JF. Catamenial pneumothorax: a prospective study. Chest 2003; 124 (03) 1004-1008
    CrossrefPubMedGoogle Scholar
  • 56 Joseph J, Sahn SA. Thoracic endometriosis syndrome: new observations from an analysis of 110 cases. Am J Med 1996; 100 (02) 164-170
    CrossrefPubMedGoogle Scholar
  • 57 Rousset-Jablonski C, Alifano M, Plu-Bureau G. , et al. Catamenial pneumothorax and endometriosis-related pneumothorax: clinical features and risk factors. Hum Reprod 2011; 26 (09) 2322-2329
    CrossrefPubMedGoogle Scholar
  • 58 Channabasavaiah AD, Joseph JV. Thoracic endometriosis: revisiting the association between clinical presentation and thoracic pathology based on thoracoscopic findings in 110 patients. Medicine (Baltimore) 2010; 89 (03) 183-188
    PubMedGoogle Scholar
  • 59 Gourgoulianis KI, Karantanas AH, Molyvdas PA. Peripartum pleural effusion. Chest 1997; 111 (05) 1467-1468
    PubMedGoogle Scholar
  • 60 Kocijancic I, Pusenjak S, Kocijancic K, Vidmar G. Sonographic detection of physiologic pleural fluid in normal pregnant women. J Clin Ultrasound 2005; 33 (02) 63-66
    CrossrefPubMedGoogle Scholar
  • 61 Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation. Am J Obstet Gynecol 2000; 183 (06) 1475-1479
    CrossrefPubMedGoogle Scholar
  • 62 Romanyuk V, Raichel L, Sergienko R, Sheiner E. Pneumonia during pregnancy: radiological characteristics, predisposing factors and pregnancy outcomes. J Matern Fetal Neonatal Med 2011; 24 (01) 113-117
    CrossrefPubMedGoogle Scholar
  • 63 Light RW. Pleural diseases in pregnancy. Int Pleural News 2006; 4: 6-7
    PubMedGoogle Scholar
  • 64 Ayres MA, Sulak PJ. Pregnancy complicated by antiphospholipid antibodies. South Med J 1991; 84 (02) 266-269
    CrossrefPubMedGoogle Scholar
  • 65 Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton III LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005; 143 (10) 697-706
    CrossrefPubMedGoogle Scholar
  • 66 Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation 2016; 133 (14) 1397-1409
    CrossrefPubMedGoogle Scholar
  • 67 Harari S, Spagnolo P, Cocconcelli E, Luisi F, Cottin V. Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis. Curr Opin Pulm Med 2018; 24 (05) 469-476
    PubMedGoogle Scholar
  • 68 Khaddour K, Shayuk M. Lymphangioleiomyomatosis. Treasure Island, FL: StatPearls; 2019
    Google Scholar
  • 69 Yu J, Astrinidis A, Howard S, Henske EP. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am J Physiol Lung Cell Mol Physiol 2004; 286 (04) L694-L700
    CrossrefPubMedGoogle Scholar
  • 70 Xu KF, Tian X, Ryu JH. Recent advances in the management of lymphangioleiomyomatosis. F1000 Res 2018; 7: 7
    CrossrefPubMedGoogle Scholar
  • 71 Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990; 323 (18) 1254-1260
    CrossrefPubMedGoogle Scholar
  • 72 Johnson SR. Lymphangioleiomyomatosis. Eur Respir J 2006; 27 (05) 1056-1065
    CrossrefPubMedGoogle Scholar
  • 73 Almoosa KF, McCormack FX, Sahn SA. Pleural disease in lymphangioleiomyomatosis. Clin Chest Med 2006; 27 (02) 355-368
    CrossrefPubMedGoogle Scholar
  • 74 Almoosa KF, Ryu JH, Mendez J. , et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest 2006; 129 (05) 1274-1281
    CrossrefPubMedGoogle Scholar
  • 75 Young LR, Almoosa KF, Pollock-Barziv S, Coutinho M, McCormack FX, Sahn SA. Patient perspectives on management of pneumothorax in lymphangioleiomyomatosis. Chest 2006; 129 (05) 1267-1273
    CrossrefPubMedGoogle Scholar
  • 76 McCormack FX, Gupta N, Finlay GR. , et al; ATS/JRS Committee on Lymphangioleiomyomatosis. Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med 2016; 194 (06) 748-761
    CrossrefPubMedGoogle Scholar
  • 77 Hillerdal G. Textbook of Pleural Disease. 2nd ed. London: Hodder Arnold; 2008
    Google Scholar
  • 78 Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49 (01) 8-31 , 1
    CrossrefPubMedGoogle Scholar
  • 79 Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 2008; 83 (02) 235-250
    CrossrefPubMedGoogle Scholar
  • 80 Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000; 117 (01) 79-86
    CrossrefPubMedGoogle Scholar
  • 81 Thomas JM, Redding WH, Sloane JP. The spread of breast cancer: importance of the intrathoracic lymphatic route and its relevance to treatment. Br J Cancer 1979; 40 (04) 540-547
    CrossrefPubMedGoogle Scholar
  • 82 Boulanger E, Gérard L, Gabarre J. , et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 2005; 23 (19) 4372-4380
    CrossrefPubMedGoogle Scholar
  • 83 Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006; 34 (05) 335-347
    CrossrefPubMedGoogle Scholar
  • 84 Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J Clin Ultrasound 2003; 31 (02) 69-74
    CrossrefPubMedGoogle Scholar
  • 85 Chian CF, Su WL, Soh LH, Yan HC, Perng WC, Wu CP. Echogenic swirling pattern as a predictor of malignant pleural effusions in patients with malignancies. Chest 2004; 126 (01) 129-134
    CrossrefPubMedGoogle Scholar
  • 86 Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154 (03) 487-492
    CrossrefPubMedGoogle Scholar
  • 87 Yilmaz U, Polat G, Sahin N, Soy O, Gülay U. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis 2005; 63 (01) 17-22
    PubMedGoogle Scholar
  • 88 Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol 2001; 56 (03) 193-196
    CrossrefPubMedGoogle Scholar
  • 89 Duysinx B, Nguyen D, Louis R. , et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 2004; 125 (02) 489-493
    CrossrefPubMedGoogle Scholar
  • 90 Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 2000; 175 (01) 245-249
    CrossrefPubMedGoogle Scholar
  • 91 Schaffler GJ, Wolf G, Schoellnast H. , et al. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET. Radiology 2004; 231 (03) 858-865
    CrossrefPubMedGoogle Scholar
  • 92 Toaff JS, Metser U, Gottfried M. , et al. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography. Invest Radiol 2005; 40 (04) 204-209
    CrossrefPubMedGoogle Scholar
  • 93 Benlloch S, Galbis-Caravajal JM, Martín C. , et al. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer 2006; 107 (08) 1859-1865
    CrossrefPubMedGoogle Scholar
  • 94 Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994; 7 (06) 665-668
    PubMedGoogle Scholar
  • 95 Nance KV, Shermer RW, Askin FB. Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol 1991; 4 (03) 320-324
    PubMedGoogle Scholar
  • 96 Ong KC, Indumathi V, Poh WT, Ong YY. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Singapore Med J 2000; 41 (01) 19-23
    PubMedGoogle Scholar
  • 97 Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985; 60 (03) 158-164
    CrossrefPubMedGoogle Scholar
  • 98 Sallach SM, Sallach JA, Vasquez E, Schultz L, Kvale P. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest 2002; 122 (06) 1913-1917
    CrossrefPubMedGoogle Scholar
  • 99 Woenckhaus M, Grepmeier U, Werner B. , et al. Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology. J Mol Diagn 2005; 7 (04) 517-524
    CrossrefPubMedGoogle Scholar
  • 100 Porcel JM. Biomarkers in the diagnosis of pleural diseases: a 2018 update. Ther Adv Respir Dis 2018; 12: 1-11
    CrossrefPubMedGoogle Scholar
  • 101 Jakubec P, Kolek V, Václavík A. , et al. Closed pleural biopsy in the diagnostics of malignant pleural involvement [in Czech]. Vnitr Lek 2014; 60 (5–6): 423-430
    PubMedGoogle Scholar
  • 102 Chakrabarti B, Ryland I, Sheard J, Warburton CJ, Earis JE. The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions. Chest 2006; 129 (06) 1549-1555
    CrossrefPubMedGoogle Scholar
  • 103 Jiménez D, Pérez-Rodriguez E, Diaz G, Fogue L, Light RW. Determining the optimal number of specimens to obtain with needle biopsy of the pleura. Respir Med 2002; 96 (01) 14-17
    CrossrefPubMedGoogle Scholar
  • 104 Bhattacharya S, Bairagya TD, Das A, Mandal A, Das SK. Closed pleural biopsy is still useful in the evaluation of malignant pleural effusion. J Lab Physicians 2012; 4 (01) 35-38
    Article in Thieme ConnectPubMedGoogle Scholar
  • 105 Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003; 361 (9366): 1326-1330
    CrossrefPubMedGoogle Scholar
  • 106 Ernst A, Hersh CP, Herth F. , et al. A novel instrument for the evaluation of the pleural space: an experience in 34 patients. Chest 2002; 122 (05) 1530-1534
    CrossrefPubMedGoogle Scholar
  • 107 Mathur PN, Astoul P, Boutin C. Medical thoracoscopy. Technical details. Clin Chest Med 1995; 16 (03) 479-486
    PubMedGoogle Scholar
  • 108 Munavvar M, Khan MA, Edwards J, Waqaruddin Z, Mills J. The autoclavable semirigid thoracoscope: the way forward in pleural disease?. Eur Respir J 2007; 29 (03) 571-574
    CrossrefPubMedGoogle Scholar
  • 109 Tassi GF, Davies RJ, Noppen M. Advanced techniques in medical thoracoscopy. Eur Respir J 2006; 28 (05) 1051-1059
    CrossrefPubMedGoogle Scholar